Ingenuity® Systems, Redwood City, Calif, a provider of biomedical information and analysis solutions, has formed a partnership with Life Technologies Corp, Carlsbad, Calif, to develop and deliver a joint solution for rapid, high-confidence interpretation of molecular profiling information from Life Technologies’ diagnostic tests.
Ingenuity Systems’ software and content will be provided to interpreting physicians, such as molecular pathologists and medical geneticists, in a dedicated portal for the interpretation of Life’s molecular diagnostic test kits. Users of this interpretation portal will be able to review disease management guidelines, identify clinical trials, and find cutting-edge insights from biomedical research.
The Ingenuity Systems solution will be made available in context with other software and database solutions, to provide a wide range of information that may help physicians to find suitable treatment options or clinical trials for patients. Through these tools, interpreting physicians will leverage the comprehensive, expert-curated Ingenuity Knowledge Base of biomedical content, including an up-to-date database of all human disease phenotype associated variants.
Results of the interpretation process will then be conveyed through a reporting portal to treating physicians. While these tools will not provide medical decisions to treating physicians, they will provide contextual information that may identify treatment options based on biological factors of a patient’s disease. Consistent with Life Technologies’ recent launch of a test for lung cancer risk stratification, the solution will initially be made available for Life Technologies’ emerging line of cancer diagnostic tests
[Source: Ingenuity Systems]
